stella
beta
Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention — Stella
Home
/
Coronary Artery Disease
/
View on ClinicalTrials.gov
Recruiting
Back to Coronary Artery Disease trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
South Korea
St. Vincent's Hospital, Suwon, Gyeonggi-do